Coelho John F

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2024-01-31	2024-01-29	Kuvatris Therapeutics Inc (PXMD)	PlS Planned sale	47,904 +46.9% 248.91 US$344,968	47,904 +46.9%	248.91	US$344,968
2023-11-29	2023-11-27	Kuvatris Therapeutics Inc (PXMD)	PlS Planned sale	55,374 -39.0% 213.05 US$30,565	55,374 -39.0%	213.05	US$30,565
2023-10-30	2023-10-27	Kuvatris Therapeutics Inc (PXMD)	PlS Planned sale	96,606 -49.4% 430.80 US$1,671,725	96,606 -49.4%	430.80	US$1,671,725
2023-08-30	2023-08-29	Kuvatris Therapeutics Inc (PXMD)	PlS Planned sale	23 -0.0% 0.49 US$11	23 -0.0%	0.49	US$11
2023-08-30	2023-08-28	Kuvatris Therapeutics Inc (PXMD)	PlS Planned sale	774 -1.0% 0.52 US$403	774 -1.0%	0.52	US$403
2023-03-09	2023-03-09	Kuvatris Therapeutics Inc (PXMD)	PlS Planned sale	130 -0.2% 1.48 US$192	130 -0.2%	1.48	US$192
2023-03-03	2023-03-02	Kuvatris Therapeutics Inc (PXMD)	PlS Planned sale	3,013 -4.3% 1.93 US$5,815	3,013 -4.3%	1.93	US$5,815